Patent ID: 11952439
Assignee: B-ONE MEDICAL BIOTECH CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The crosslinking method according to claim 4, wherein the antioxidant is one or more selected from the following group: Vitamin E, Tetrakis[methylene(3,5-di-tert-butylhydroxyhydrocinnamate)]methane, Thiodiethylene bis[3-[3,5-di-tert-butyl-4-hydroxyphenyl]propionate], Octadecyl 3,5-di-tert-butyl-4-hydroxylhydrocinnamate, N,N′-hexane-1,6-diylbis(3-(3,5-di-tert-butyl-4-hydroxyphenylpropionamide)), Benzenepropanoic acid, 3,5-bis(1,1-dimethyl-ethyl)-4-hydroxy-C7-C9 branched alkyl esters, 1,3,5-TRis(3,5-di-tert-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene, 2,4-bis(dodecylthiomethyl)-6-methylphenol, Triethylene glycol bis(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate, 2,2′-methylenebis(4-methyl-6-tert-butylphenol)monoacrylate, 1,3,5-TRis(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione, Benzenamine,N-phenyl-,reaction products with 2,4,4-trimethylpentene, 2,4-bis(octylthio)-6-(4-hydroxy-3,5-di-tert-butylanilino)-1,3,5-triazine, 5,7-di-t-butyl-3-(3,4 di-methylphenyl)-3H-benzofuran-2-one, Tris(2,4-di-tert-butylphenyl)phospite and Pentaerythritol tetra [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate].